Download FREE Report Sample
Download Free sampleRemdesivir Market contains market size and forecasts of Remdesivir (COVID-19) in global, including the following market information:
Global Remdesivir (COVID-19) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Remdesivir (COVID-19) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Remdesivir (COVID-19) companies in 2021 (%)
The global Remdesivir (COVID-19) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Remdesivir (COVID-19) include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group and Inovio Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Remdesivir (COVID-19) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remdesivir (COVID-19) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, by Type, 2021 (%)
5mg
10mg
50mg
100mg
Global Remdesivir (COVID-19) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Drug Store
Others
Global Remdesivir (COVID-19) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remdesivir (COVID-19) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Remdesivir (COVID-19) revenues share in global market, 2021 (%)
Key companies Remdesivir (COVID-19) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Remdesivir (COVID-19) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
